Julia Neugebauer 

  •                                 
    Extbase Variable Dump
    'distribution:BiomSpeaker.html' (29 chars)
    
                            
  •                                     
    Extbase Variable Dump
    'fileadmin/Webdata/Uploads/Veranstaltungen/2025/BayOConnect_2025/Speaker/Neug
     ebauer_300x300.jpg    ' (94 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Julia Neugebauer' (16 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Chief Operating Officer, Vivoryon Therapeutics' (46 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Julia Neugebauer currently is Chief Operating Officer of Vivoryon Therapeuti
     cs N.V., where she oversees Investor Relations &  Communications, Market Ana
     lysis and other corporate functions. In her previous role as Vice President,
      Global Head of Investor Relations & Sustainability at MorphoSys AG, she led
      all investor relations activities and was a member of the Finance Leadershi
     p Team. Dr. Neugebauer brings deep expertise in developing and executing glo
     bal investor relations strategies, with a strong track record of cultivating
      long-term relationships with institutional investors and both buy- and sell
     -side analysts. She played a key role in shaping investor messaging around c
     orporate milestones, clinical data, and financial performance. She started h
     er career in investor relations after more than 10 years in R&D, with a focu
     s on antibody engineering and development. Dr. Neugebauer holds a PhD from t
     he Ludwig-Maximilians-Universität München, Germany, and is a Certified Inves
     tor Relations Officer (CIRO) through the Frankfurt School of Finance & Manag
     ement. www.linkedin.com/in/julia-neugebauer-phd/    ' (1112 chars)